Bronchiolitis Completed Phase 3 Trials for Nitric Oxide (DB00435)

IndicationStatusPhase
DBCOND0013705 (Bronchiolitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03053388Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With BronchiolitisTreatment